Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity

por Agrawal, Archita, Parlee, Sebastian, Perez-Tilve, Diego, Li, Pengyun, Pan, Jia, Mroz, Piotr A., Kruse Hansen, Ann Maria, Andersen, Birgitte, Finan, Brian, Kharitonenkov, Alexei, DiMarchi, Richard D.
Publicado 2018

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice

por Knerr, Patrick J., Mowery, Stephanie A., Douros, Jonathan D., Premdjee, Bhavesh, Hjøllund, Karina Rahr, He, Yantao, Kruse Hansen, Ann Maria, Olsen, Anette K., Perez-Tilve, Diego, DiMarchi, Richard D., Finan, Brian
Publicado 2022

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems

por Yang, Bin, Gelfanov, Vasily M., El, Kimberley, Chen, Alex, Rohlfs, Rebecca, DuBois, Barent, Kruse Hansen, Ann Maria, Perez-Tilve, Diego, Knerr, Patrick J., D'Alessio, David, Campbell, Jonathan E., Douros, Jonathan D., Finan, Brian
Publicado 2022